Novartis Aktie: Ein Zeichen des Wachstums!
Die Novartis-Aktie verzeichnete am jüngsten Handelstag eine positive Entwicklung an der Schweizer Börse SIX. Im Tagesverlauf stieg der Kurs um 0,7 Prozent auf 92,62 CHF, nachdem er bei 91,90 CHF in de ...
Schrodinger’s Strategic Collaborations and Financial Position Bolster Buy Rating Amid Market Confidence and Future Growth Potential
Leerink Partners analyst Mani Foroohar has maintained their bullish stance on SDGR stock, giving a Buy rating yesterday. Mani Foroohar has ...
Crain's New York12h
Midtown-based drug company inks $150M deal with Novartis
Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...
Business Insider16h
Schrodinger price target raised to $28 from $27 at Goldman Sachs
The company’s Q3 results and announced deal with Novartis (NVS) involving both a research and expanded software utilization collaboration drove the stock higher, and while operating results from the ...
InnovationRx: Positive Clinical Trial Results For Generative AI-Designed Drug
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
Hoodline22h
Schrödinger Strikes $150M Deal With Novartis, Potential for $2.3B in Future Payments
In a significant stride within the pharmaceutical industry, Midtown's own Schrödinger has clinched a deal with healthcare ...